Static becomes dynamic, with a seamless flow of information – and now physicians will have the data at their fingertips to bring care to the next level from hospital to home. With the integration of data into MUSE, the physician can compare the patient’s most recent KardiaMobile 6L ECG to prior ECGs or other relevant results, expanding diagnostic capabilities through continuity of care.īy building a workflow in MUSE that integrates the ECG data from KardiaMobile 6L into the EMR, GE Healthcare’s advanced 510(k)-cleared ECG interpretation “EK12” algorithms and AliveCor’s 510(k)-cleared artificial intelligence are solving this challenge.
However, because the data is not integrated into the clinical workflow of the EMR or MUSE, the physician cannot easily compare the results to prior ECGs or relevant results from other diagnostic tools and tests.
#Fototube ge healthcare pdf#
“The KardiaMobile 6L allows patients to conveniently monitor their heart health in any environment, and by integrating its data directly into MUSE, we are offering hospitals and health systems an unprecedented amount of information to leverage for patient care within their existing clinical workflow – with the ultimate goal of improving patient outcomes and reducing the number of cardiac-related hospitalizations and the costs associated with them.”Ĭurrently, if the patient chooses to share the remote ECG, a physician sees AliveCor six-lead ECGs on a patient’s phone in an office visit or a PDF emailed by the patient. “By teaming up with AliveCor, we are strengthening the connection between personal health and clinical decision making to transform cardiac care to be more convenient for patients and actionable for providers,” said Tom Westrick, President, and CEO of GE Healthcare’s Life Care Solutions business. With this partnership, not only are the ECGs analyzed by GE Healthcare’s algorithms, they become part of the patient record in MUSE and the EMR so that any physician in the network involved in the patient’s care can interact with them. GE Healthcare’s MUSE, used by 87 percent of the top cardiac hospitals in the U.S., is a vendor-agnostic solution that connects with a hospital’s EMR to manage and streamline the flow of cardiac information, enabling faster data delivery, distribution, and analysis for more informed decisions and improved patient care. alone, more than 454,000 patients are hospitalized and 158,000 deaths are attributed to atrial fibrillation each year. AliveCor’s FDA-cleared, AI-enabled KardiaMobile 6L ECG device aids in the efficient detection of atrial fibrillation, as well as the detection of other heart rhythm conditions.
Ītrial fibrillation, the most common type of treated heart arrhythmia, is associated with a highly elevated risk of stroke. This integration offers physicians access to trusted patient data within their existing workflow, helping to increase their diagnostic confidence and improving the ability to effectively manage patients proactively across the care continuum – with the goal of reducing hospitalizations linked to cardiac conditions, including but not limited to atrial fibrillation. ORLANDO – Ma– Today, GE Healthcare and AliveCor announced a partnership to deliver medical-grade six-lead electrocardiograms (ECGs) taken by patients on an AliveCor KardiaMobile 6L ECG device outside of the hospital setting – at home or on the go – directly into GE Healthcare’s MUSE Cardiac Management System for physicians to view and evaluate.
0 kommentar(er)
